Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade D 22.35 0.04% 0.01
BHC closed up 0.04 percent on Wednesday, January 16, 2019, on 64 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Down Up
See historical BHC trend table...

Date Alert Name Type % Chg
Jan 16 200 DMA Resistance Bearish 0.00%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 16 Narrow Range Bar Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 200 DMA Resistance Bearish 0.04%
Jan 15 MACD Bullish Centerline Cross Bullish 0.04%
Jan 15 Wide Bands Range Expansion 0.04%
Jan 15 Overbought Stochastic Strength 0.04%
Jan 14 Fell Below 200 DMA Bearish 0.45%

Older signals for BHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.45
52 Week Low 14.44
Average Volume 4,937,857
200-Day Moving Average 22.4593
50-Day Moving Average 22.932
20-Day Moving Average 20.606
10-Day Moving Average 22.22
Average True Range 1.077
ADX 18.42
+DI 27.7131
-DI 20.0861
Chandelier Exit (Long, 3 ATRs ) 21.359
Chandelier Exit (Short, 3 ATRs ) 20.431
Upper Bollinger Band 24.2528
Lower Bollinger Band 16.9592
Percent B (%b) 0.74
BandWidth 35.395516
MACD Line 0.0744
MACD Signal Line -0.3031
MACD Histogram 0.3775
Fundamentals Value
Market Cap 7.8 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -6.83
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.04
Resistance 3 (R3) 23.10 22.92 22.93
Resistance 2 (R2) 22.92 22.75 22.90 22.89
Resistance 1 (R1) 22.64 22.64 22.55 22.58 22.85
Pivot Point 22.46 22.46 22.42 22.44 22.46
Support 1 (S1) 22.18 22.29 22.09 22.12 21.85
Support 2 (S2) 22.00 22.18 21.98 21.81
Support 3 (S3) 21.72 22.00 21.78
Support 4 (S4) 21.66